Client Views and Attitudes to Non-Invasive Prenatal Diagnosis for Sickle Cell Disease, Thalassaemia and Cystic Fibrosis

Journal of Genetic Counseling

Volumn 23, Issue 6, 2014, Pages 1012-1021

  Hill, Melissa ^a,d   Compton, Cecilia ^b   Karunaratna, Madhavi ^b   Lewis, Celine ^c   Chitty, Lyn ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c GENETIC ALLIANCE UK   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cell free fetal DNA; Decision making; Genetic counseling; Non invasive prenatal diagnosis; Single gene disorders

Indexed keywords

ADULT; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; CYSTIC FIBROSIS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETICS; HUMAN; INFORMATION PROCESSING; MALE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; QUALITATIVE RESEARCH; THALASSEMIA;

ADULT; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; CYSTIC FIBROSIS; DECISION MAKING; FEMALE; FOCUS GROUPS; GENETIC COUNSELING; HUMANS; MALE; PREGNANCY; PRENATAL DIAGNOSIS; QUALITATIVE RESEARCH; THALASSEMIA;

EID: 84911987311     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9725-4     Document Type: Article

References (36)

1. Barrett, A. N., McDonnell, T. C., Chan, K. C., & Chitty, L. S. (2012). Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clinical Chemistry, 58(6), 1026–1032.
2. Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.
3. Bustamante-Aragones, A., Rodriguez de Alba, M., Perlado, S., Trujillo-Tiebas, M. J., Arranz, J. P., Diaz-Recasens, J., et al. (2012). Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene, 504(1), 144–149.
4. Chitty, L. S., Griffin, D. R., Meaney, C., Barrett, A., Khalil, A., Pajkrt, E., et al. (2011). New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound in Obstetrics and Gynecology, 37(3), 283–289.
5. Chitty, L. S., Khalil, A., Barrett, A. N., Pajkrt, E., Griffin, D. R., & Cole, T. J. (2013). Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenatal Diagnosis, 33(5), 416–423.
6. Clinical Molecular Genetics Society (CMGS) (2013). Audit 2011–2012. Available from http://www.cmgs.org/CMGS%20audit/2012%20audit/CMGSAudit11_12_FINAL.pdf, Accessed May 2013.
7. de Jong, A., Dondorp, W. J., de Die-Smulders, C. E., Frints, S. G., & de Wert, G. M. (2010). Non-invasive prenatal testing: ethical issues explored. European Journal of Human Genetics, 18(3), 272–277.
8. de Jong, A., Dondorp, W. J., Frints, S. G., de Die-Smulders, C. E., & de Wert, G. M. (2011). Advances in prenatal screening: the ethical dimension. Nature Reviews Genetics, 12(9), 657–663.
9. Deans, Z., & Newson, A. J. (2011). Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Analysis, 19(2), 122–132.
10. Deans, Z., Hill, M., Chitty, L. S., & Lewis, C. (2013). Non-invasive prenatal testing for single gene disorders: exploring the ethics. European Journal of Human Genetics, 21(7), 713–718.
11. Dormandy, E., Gulliford, M., Bryan, S., Roberts, T. E., Calnan, M., Atkin, K., et al. (2010). Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ, 341, c5132.
12. D'Souza, E., Sawant, P. M., Nadkarni, A. H., Gorakshakar, A., Ghosh, K., & Colah, R. B. (2013). Detection of fetal mutations causing hemoglobinopathies by non-invasive prenatal diagnosis from maternal plasma. Journal of Postgraduate Medicine, 59(1), 15–20.
13. Hall, A., Bostanci, A., & Wright, C. F. (2010). Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics, 13(4), 246–255.
14. Hill, M., Finning, K., Martin, P., Hogg, J., Meaney, C., Norbury, G., et al. (2011). Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clinical Genetics, 80(1), 68–75.
15. Hill, M., Compton, C., Lewis, C., Skirton, H., & Chitty, L. S. (2012). Determination of foetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom. Haemophilia, 18(4), 575–583.
16. Hill, M., Karunaratna, M., Lewis, C., Forya, F., & Chitty, L. (2013). Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. American Journal of Medical Genetics Part A, 161A(7), 1612–1618.
17. Hodgson, J., & Spriggs, M. (2005). A practical account of autonomy: why genetic counseling is especially well suited to the facilitation of informed autonomous decision making. Journal of Genetic Counseling, 14(2), 89–97.
18. Kelly, S. E., & Farrimond, H. R. (2012). Non-invasive preantal genetic testing: A study of public attitudes. Public Health Genomics, 15(2), 73–81.
19. Kitzinger, J. (2006). Focus groups qualitative research in health care (3rd ed.). BMJ Books: C. Pope and N. Mays. London.
20. Lench, N., Barrett, A., Fielding, S., McKay, F., Hill, M., Jenkins, L., et al. (2013). The clinical implementation of non-invasive prenatal diagnosis for single gene disorders: challenges and progress made. Prenatal Diagnosis, 33(3), 555–562.
21. Lerman, C., Croyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70(3), 784–797.
22. Lewis, C., Hill, M., Skirton, H., & Chitty, L. S. (2012a). Fetal sex determination using cell-free fetal DNA: service users’ experiences of and preferences for service delivery. Prenatal Diagnosis, 32(8), 735–741.
23. Lewis, C., Hill, M., Skirton, H., & Chitty, L. S. (2012b). Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users’ perspective. European Journal of Human Genetics, 20(11), 1127–1133.
24. Lewis, C., Hill, M., Chitty, L. S. (2014). Non-invasive prenatal diagnosis for single gene disorders: experience of patients. Clinical Genetics, 85(4), 336–342.
25. Lo, Y., Chan, K., Sun, H., Chen, E., Jiang, P., Lun, F., et al. (2010). Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine, 2(61), 61ra91.
26. Lun, F. M., Tsui, N. B., Chan, K. C., Leung, T. Y., Lau, T. K., Charoenkwan, P., et al. (2008). Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America, 105(50), 19920–19925.
27. Michie, S., Smith, J. A., Senior, V., & Marteau, T. M. (2003). Understanding why negative genetic test results sometimes fail to reassure. American Journal of Medical Genetics Part A, 119A(3), 340–347.
28. Pergament, E., & Pergament, D. (2012). Reproductive decisions after fetal genetic counselling. Best Practice and Research Clinical Obstetrics and Gynaecology, 26(5), 517–529.
29. Ropka, M. E., Wenzel, J., Phillips, E. K., Siadaty, M., & Philbrick, J. T. (2006). Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiology, Biomarkers and Prevention, 15(5), 840–855.
30. Sanderson, S. C., O’Neill, S. C., Bastian, L. A., Bepler, G., & McBride, C. M. (2010). What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics, 13(2), 116–124.
31. Sayres, L. C., Allyse, M., Norton, M. E., & Cho, M. K. (2011). Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis, 31(11), 1070–1076.
32. Sayres, L. C., Allyse, M., & Cho, M. K. (2012). Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy. Genome Medicine, 4(6), 49.
33. Skirton, H., & Patch, C. (2013). Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review. Prenatal Diagnosis, 33(6), 532–541.
34. Tabor, A., & Alfirevic, Z. (2010). Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy, 27(1), 1–7.
35. Tischler, R., Hudgins, L., Blumenfeld, Y. J., Greely, H. T., & Ormond, K. E. (2011). Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenatal Diagnosis, 31(13), 1292–1299.
36. Yotsumoto, J., Sekizawa, A., Koide, K., Purwosunu, Y., Ichizuka, K., Matsuoka, R., et al. (2012). Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan. Prenatal Diagnosis, 32(7), 674–679.